Logo image of MBII

Marrone Bio Innovations Inc (MBII) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:MBII - US57165B1061 - Common Stock

0.7981
-0.2 (-20.19%)
Last: 7/12/2022, 8:00:01 PM
0.81
+0.01 (+1.49%)
After Hours: 7/12/2022, 8:00:01 PM
Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to MBII. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1.4. This target is 75.73% above the current price.
MBII was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about MBII.
In the previous month the buy percentage consensus was at a similar level.
MBII was analyzed by 10 analysts. More opinions would make the average more meaningful.

Related screens

MBII Historical Analyst RatingsMBII Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -67 -61 -55 -49 -43 -37 -31 -25 -19 -13 -7 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.800.911.331.402.10 - 13.90% 66.14% 75.73% 163.12%

Related screens

MBII Current Analyst RatingMBII Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2021-09-22 Roth Capital Initiate Buy
2021-08-19 Aegis Capital Maintains Buy
2021-02-11 Aegis Capital Maintains Buy

Marrone Bio Innovations Inc / MBII FAQ

Can you provide the average price target for Marrone Bio Innovations Inc stock?

10 analysts have analysed MBII and the average price target is 1.4 null. This implies a price increase of 75.73% is expected in the next year compared to the current price of 0.7981.


Can you provide the consensus rating for Marrone Bio Innovations Inc stock?

The consensus rating for Marrone Bio Innovations Inc (MBII) is 78 / 100 . This indicates that analysts generally have a positive outlook on the stock.